Skip to content

A clinical study on the effect of enteral nutrition containing PHGG on enteral nutrition tolerance and incidence of sepsis in patients with multiple injuries

A clinical study on the effect of enteral nutrition containing PHGG on enteral nutrition tolerance and incidence of sepsis in patients with multiple injuries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066926
Enrollment
Unknown
Registered
2022-12-21
Start date
2023-01-01
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple injuries,Sepsis

Interventions

Experimental group:Contains PHGG enteral nutrition

Sponsors

Northern Jiangsu People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 ~ 70 years; 2. Meet the diagnostic criteria for multiple injuries and have an ISS score of > 16 points on admission; 3. Be at risk of malnutrition after nutritional screening and have indications for nutritional support; 4. Start EN within 5 days of injury; 5. The patient has no prior history of malnutrition or diabetes; 6. The patient has no functional digestive system disease in the last 6 months; 7. Informed consent for this study signed by the patient's immediate family or guardian upon admission.

Exclusion criteria

Exclusion criteria: 1. The trauma patient is admitted to the hospital without an immediate family member or guardian; 2. Pregnancy and obesity (body weight > 150 per cent ideal body weight); 3. A previous history of HIV infection, immunosuppressive disease or immunosuppressive therapy; 4. The terminal stage of various diseases, such as malignant tumors, cancer and other diseases; 5. Exclude patients with previous hyperthyroidism, cirrhosis and other diseases; 6. Use of antibiotics, hormones or immunosuppressants, oral probiotics, prebiotics, etc. in the past month; 7. Patients with infectious diseases prior to admission; 8. Those who are allergic to milk protein; 9. Other healthcare professionals who deem it inappropriate to participate in this study.

Design outcomes

Primary

MeasureTime frame
Enteral nutrition tolerance score on day 7;

Secondary

MeasureTime frame
Sepsis incidence during ICU;Day 7 nutritional status;Fecal probiotic content on day 7;Day 28 quality of life score;Length of ICU stay;Duration of mechanical ventilation;28-day mortality;

Countries

China

Contacts

Public ContactDingyu Tan

Northern Jiangsu People's Hospital

32494845@qq.com18051061672

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026